NCT05346107 2022-04-26PLD-cyclophosphamide-Nab-P Continuously Combined With Dual HER2 Blockage for HER2-positive Breast CancerXijing HospitalPhase 2 Unknown100 enrolled
NCT03949634 2019-05-14Cardiac Safety and Efficacy for Early-stage Breast Cancer Patients Treated With Pegylated Liposomal Doxorubicin（PLD)Fudan UniversityPhase 3 Unknown272 enrolled